Home » Topics » BioWorld Science

BioWorld Science
RSS

U.S. phase III trials of Remune begin

March 15, 1996

Nitazoxanide advances in phase II

March 15, 1996

Neupogen approved for AIDS-related indication

March 15, 1996

Alpha Leukoferon to be tested in HIV-infected hemophiliacs

March 15, 1996

Cidofovir approval recommended by committee

March 15, 1996

MDX-240 promising in HIV trials

March 15, 1996

Nagrestip tested for use in HIV

March 15, 1996

Cel-Sci's AIDS vaccine demonstrates efficacy

March 15, 1996

British Biotech abandons HIV candidate

March 15, 1996

FDA approves HIV drug

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...